<?xml version="1.0" encoding="UTF-8"?>
<results title="drug">
 <result pre="None Not requiring vasopressors Requiring a vasopressor with or without" exact="vasopressin" post="Requiring multiple vasopressors (excluding vasopressin) And/orb Hypoxia None Requiring"/>
 <result pre="triggers the increase of body temperature through the release of" exact="prostaglandin E2" post="(PGE2). Tocilizumab is indicated for adult patients with autoimmune"/>
 <result pre="to treat CRS is being reported [26]. Baricitinib, fedratinib and" exact="ruxolitinib" post="are potent and selective JAK inhibitors approved for indications"/>
 <result pre="potential benefit for Bruton's tyrosine kinase (BTK) inhibitors such as" exact="ibrutinib" post="(ImbruvicaTM) to protect against lung pathology in patients with"/>
 <result pre="SARS-CoV-2 pneumonia [44]. Therefore, further antiviral agents have been proposed." exact="Hydroxychloroquine" post="and chloroquine are drugs that interfere with digestive vacuole"/>
 <result pre="[44]. Therefore, further antiviral agents have been proposed. Hydroxychloroquine and" exact="chloroquine" post="are drugs that interfere with digestive vacuole function within"/>
 <result pre="neutrophils and chemotaxis of eosinophils and; impair complement-dependent antigen-antibody reactions." exact="Chloroquine" post="has been used for malaria treatment and chemoprophylaxis and"/>
 <result pre="Chloroquine has been used for malaria treatment and chemoprophylaxis and" exact="hydroxychloroquine" post="is used for treatment of several autoimmune conditions including"/>
 <result pre="arthritis. Both drugs have in vitro activity against coronaviruses, with" exact="hydroxychloroquine" post="having relatively higher potency against SARS-CoV-2 [45]. On the"/>
 <result pre="On the basis of limited in vitro and anecdotal data," exact="chloroquine" post="or hydroxychloroquine administered either with or without azithromycin (a"/>
 <result pre="basis of limited in vitro and anecdotal data, chloroquine or" exact="hydroxychloroquine" post="administered either with or without azithromycin (a macrolide with"/>
 <result pre="anecdotal data, chloroquine or hydroxychloroquine administered either with or without" exact="azithromycin" post="(a macrolide with anti-inflammatory properties) have been recommended for"/>
 <result pre="of emapalumab (anti-interferon-Î³ monoclonal antibody Sobi-IMMUNO-101 study) and the antiparasitic" exact="ivermectin" post="[48]. To date, more than 600 worldwide studies and"/>
 <result pre="haemophagocytic lymphohistiocytosis: an open-label, single-centre, pilot trialLancet Haematol62019e630e63731537486 27TreonS.P.CastilloJ.SkarbnikA.P.SoumeraiL.D.GhobrialI.M.GuerreraM.L.The BTK-inhibitor" exact="ibrutinib" post="may protect against pulmonary injury in COVID-19 infected patientsBlood13520201912191532302379"/>
 <result pre="adults hospitalized with severe COVID-19N Engl J Med38220201787179932187464 45WangM.CaoR.ZhangL.YangX.LiuJ.XuM.Remdesivir and" exact="chloroquine" post="effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in"/>
 <result pre="patients with severe Covid-19N Engl J Med38220202327233610.1056/NEJMoa200701632275812 48CalyL.DruceJ.D.CattonM.G.JansD.A.WagstaffK.M.The FDA-approved drug" exact="ivermectin" post="inhibits the replication of SARS-CoV-2 in vitroAntiviral Res1782020104787 49Rome"/>
</results>
